On this page
DYT6 mixed dystonia
This condition leads to twisting and repetitive movements or abnormal postures due to uncontrolled muscle activity. It typically affects individuals in early adulthood and is caused by changes in the THAP1 gene.
Overview
DYT6 mixed dystonia is a type of dystonia, which is a neurological movement disorder characterised by sustained or intermittent muscle contractions. These contractions cause abnormal, often repetitive, movements or postures [PMID:24076356]. In DYT6 mixed dystonia, the condition is specifically linked to genetic changes in the THAP1 gene. The term 'mixed' indicates that the dystonia can affect various parts of the body, rather than being limited to a single area. It is considered a rare disorder, though its exact prevalence in the UK population is not well established.
Symptoms & clinical features
Individuals with DYT6 mixed dystonia typically experience symptoms that begin during childhood or adolescence, though onset in adulthood is also possible. The initial signs often include writer's cramp, speech difficulties (dysarthria), or neck dystonia (torticollis) [PMID:22081512]. As the condition progresses, the involuntary muscle contractions may spread to other areas, such as the face, jaw, trunk, or arms and legs. These contractions can lead to twisting movements, tremors, and unusual body postures, which may be painful and interfere with daily activities. The severity of symptoms can vary significantly among affected individuals, even within the same family.
Video: Genetics 101
Affected organs
DYT6 mixed dystonia primarily affects the muscles and the central nervous system, particularly the areas of the brain involved in controlling movement. The involuntary muscle contractions manifest in various skeletal muscles throughout the body. While the condition does not directly damage organs like the heart or kidneys, the sustained muscle activity and abnormal postures can lead to musculoskeletal complications, discomfort, and impact overall physical function and quality of life.
Risks & severity
The age of symptom onset for DYT6 mixed dystonia typically ranges from childhood to early adulthood, though it can vary. The severity of dystonia can differ widely, even among individuals with the same genetic change, with some experiencing mild, localised symptoms and others having more widespread, debilitating forms [PMID:24076356]. The condition is generally progressive, meaning symptoms may worsen or spread over time, though the rate of progression is variable. While DYT6 mixed dystonia is primarily a movement disorder, some research suggests a potential association with certain psychiatric features, such as anxiety or depression, in some individuals.
Genetic causes
DYT6 mixed dystonia is caused by pathogenic variants in the THAP1 gene. The THAP1 gene provides instructions for making a protein called THAP domain containing 1. This protein is believed to play a role in regulating gene activity and cell growth, particularly in the brain. The THAP1 protein is found in the nucleus of cells and is thought to be involved in processes that control the health and function of nerve cells. Pathogenic variants in THAP1 are thought to disrupt these normal cellular processes, leading to the abnormal movements characteristic of dystonia. The exact mechanism by which THAP1 dysfunction leads to dystonia is still an area of active research.
- THAP1 THAP domain containing 1
Inheritance pattern
DYT6 mixed dystonia follows an autosomal dominant inheritance pattern. This means that a person only needs one copy of the altered THAP1 gene in each cell to develop the condition. If a person has DYT6 mixed dystonia, there is a 50% chance with each pregnancy that their child will inherit the pathogenic variant and therefore also be at risk of developing the condition. even within the same family, individuals who inherit the altered gene may experience different symptoms, or some might not develop symptoms at all (known as reduced penetrance). Family members considering starting a family may wish to seek genetic counselling.
Each child has a 50% chance of inheriting the pathogenic variant, regardless of sex.
Diagnosis & testing
Diagnosing DYT6 mixed dystonia typically involves a clinical evaluation by a neurologist, who will assess the characteristic involuntary muscle contractions and review the patient's medical history. Genetic testing is then used to confirm the diagnosis by identifying a pathogenic variant in the THAP1 gene. In the UK, genetic testing for dystonia, including specific gene panels, can be accessed through the NHS Genomic Medicine Service (GMS). Referral for genetic testing is typically made by a specialist clinician, often a neurologist, within an NHS trust. The relevant R-codes for this testing would fall under the broader categories for dystonia gene panels, which a genetics clinician can advise on.
Management & lifestyle
While there is no cure for DYT6 mixed dystonia, management focuses on alleviating symptoms and improving quality of life. Treatment options can include medications such as anticholinergics, muscle relaxants, or benzodiazepines, which can help to reduce muscle spasms. Botulinum toxin injections are often effective for focal dystonia, where injections directly into affected muscles can temporarily paralyse them and reduce involuntary contractions. Physical therapy, occupational therapy, and speech therapy can also play a crucial role in maintaining function and managing daily challenges. In some severe cases, deep brain stimulation (DBS) surgery may be considered as an option to help control movement symptoms. All management plans should be developed in consultation with a specialist neurologist within the NHS.
UK care pathway
In the UK, individuals suspected of having genetic conditions like DYT6 mixed dystonia can access care through the NHS Genomic Medicine Service (GMS). This pathway typically begins with a referral from a general practitioner or specialist to a clinical genetics service or specialist neurology centre. Genetic counsellors play a key role in providing information, support, and guidance regarding genetic testing, inheritance patterns, and the implications for both the affected individual and their family. Genetic testing for dystonia is offered through the GMS; specific R-codes for gene panels will be used by referring clinicians.
Frequently asked questions
What is the likelihood of my children inheriting DYT6 mixed dystonia?
Since DYT6 mixed dystonia is inherited in an autosomal dominant pattern, each child of an affected individual has a 50% chance of inheriting the pathogenic THAP1 gene variant. However, not everyone who inherits the variant will develop symptoms, or the symptoms may be very mild.
Can stress make DYT6 mixed dystonia symptoms worse?
Many individuals with dystonia report that their symptoms can be exacerbated by stress, anxiety, fatigue, or excitement. While these factors do not cause the condition, managing them can sometimes help to reduce the severity of symptoms.
Are there different types of DYT6 dystonia?
DYT6 refers specifically to dystonia caused by variants in the THAP1 gene. The term 'mixed dystonia' describes the pattern of muscle involvement, meaning it can affect various parts of the body, not just a single area.
Will my symptoms always get worse over time?
DYT6 mixed dystonia is often a progressive condition, meaning symptoms may worsen or spread over time. However, the rate and extent of progression are highly variable among individuals, and some may experience periods of stability. Your neurologist can provide more personalised information.
What is the typical age of onset for DYT6 mixed dystonia?
While symptoms can begin at any age, DYT6 mixed dystonia typically manifests during childhood or adolescence. Onset in early adulthood is also common, but it is less frequent for symptoms to first appear in later adult life.